Loading…

SUN-LB064 A Phase 2, Dose-Escalation, Safety and Efficacy Study of Tildacerfont (SPR001) for the Treatment of Patients with Classic Congenital Adrenal Hyperplasia

Saved in:

Bibliographic Details
Published in:	Journal of the Endocrine Society 2019-04, Vol.3 (Supplement_1)
Main Authors:	Sarafoglou, Kyriakie, Newfield, Ron, Vogiatzi, Maria, Imel, Erik, Odugbesan, A., Madu, Ivy-Joan, Nakhle, Samer, Howerton, Alexis, Huang, Michael, Vandever, Kelly, Lin, Rong, Wu-Zhang, Alyssa, Auchus, Richard
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!